MLchartDataset catalogue

PT-100

Term · Oncology and biomedicine · MLC-T-ONC-007063

A substance being studied in the treatment of cancer, including certain types of lung, pancreas, and brain cancer. PT-100 may help the immune system block the growth of cancer cells. It may also increase the growth of new blood cells. It is a type of enzyme inhibitor. Also called talabostat mesylate.

Table 1. Record
IdentifierMLC-T-ONC-007063
FieldOncology and biomedicine
Expansionstalabostat mesylate
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-007063",
  "term": "PT-100",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer, including certain types of lung, pancreas, and brain cancer. PT-100 may help the immune system block the growth of cancer cells. It may also increase the growth of new blood cells. It is a type of enzyme inhibitor. Also called talabostat mesylate.",
  "expansions": [
    "talabostat mesylate"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/pt-100/"
}

Record 13,841 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.